Quick Answer ACI WORLDWIDE, INC. reported Diluted EPS of $2.16 per share for fiscal year 2025. ACI WORLDWIDE, INC. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $2.16 +13.1% 2024 $1.91 +70.5% 2023 $1.12 -9.7% 2022 $1.24 +14.8% 2021 $1.08 +74.2% 2020 $0.62 +8.8% 2019 $0.57 -3.4% 2018 $0.59 +1375.0% 2017 … Read more
Quick Answer ACI WORLDWIDE, INC. reported Net Income of $226.66 million for fiscal year 2025. ACI WORLDWIDE, INC. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $226.66M +11.6% 2024 $203.12M +67.2% 2023 $121.51M -14.5% 2022 $142.18M +11.3% 2021 $127.79M +75.9% 2020 $72.66M +8.3% 2019 $67.06M -2.7% 2018 $68.92M +1242.2% 2017 $5.13M … Read more
Quick Answer ACI WORLDWIDE, INC. reported Revenue (ASC 606) of $1.76 billion for fiscal year 2025. ACI WORLDWIDE, INC. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $1.76B +10.4% 2024 $1.59B +9.8% 2023 $1.45B +2.2% 2022 $1.42B +3.7% 2021 $1.37B — Quarterly Revenue (ASC 606) Quarter Ending Revenue (ASC … Read more
Quick Answer ACI WORLDWIDE, INC. reported Total Revenue of $1.76 billion for fiscal year 2025. ACI WORLDWIDE, INC. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $1.76B +10.4% 2024 $1.59B +9.8% 2023 $1.45B +2.2% 2022 $1.42B +3.7% 2021 $1.37B +33.8% 2017 $1.02B +1.8% 2016 $1.01B -3.9% 2015 $1.05B +2.9% 2014 $1.02B … Read more
Quick Answer ACI WORLDWIDE, INC. reported Total Revenue of $1.76 billion for fiscal year 2025. ACI WORLDWIDE, INC. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $1.76B+10.4% $1.59B+9.8% $1.45B+2.2% $1.42B+3.7% $1.37B — Revenue (ASC 606) $1.76B+10.4% $1.59B+9.8% $1.45B+2.2% $1.42B+3.7% $1.37B — Net Income $226.66M+11.6% $203.12M+67.2% $121.51M-14.5% $142.18M+11.3% $127.79M+75.9% $72.66M+8.3% … Read more
Quick Answer AC Immune SA reported Total Assets of $154.25 million for fiscal year 2025. AC Immune SA Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $154.25M -33.2% 2024 $230.91M +26.3% 2023 $182.81M -1.7% 2022 $185.94M -28.9% 2021 $261.44M +9.5% 2020 $238.74M -20.2% 2019 $299.25M +52.2% 2018 $196.56M +48.9% 2017 $132.01M … Read more
Quick Answer AC Immune SA reported R&D Expense of $56.44 million for fiscal year 2025. AC Immune SA R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $56.44M -9.8% 2024 $62.57M +14.6% 2023 $54.61M -9.5% 2022 $60.34M -3.1% 2021 $62.28M +4.7% 2020 $59.49M +18.0% 2019 $50.43M +13.9% 2018 $44.28M +35.6% 2017 $32.66M … Read more
Quick Answer AC Immune SA reported Total Assets of $154.25 million for fiscal year 2025. AC Immune SA — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Assets $154.25M-33.2% $230.91M+26.3% $182.81M-1.7% $185.94M-28.9% $261.44M+9.5% $238.74M-20.2% R&D Expense $56.44M-9.8% $62.57M+14.6% $54.61M-9.5% $60.34M-3.1% $62.28M+4.7% $59.49M+18.0% AC Immune SA reported Total Assets of $154.25 million … Read more
Quick Answer AMERICAN COASTAL INSURANCE Corp reported Operating Income of $140.28 million for fiscal year 2025. AMERICAN COASTAL INSURANCE Corp Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $140.28M +40.8% 2024 $99.60M +6.1% 2023 $93.85M +1183.6% 2022 -$8.66M +17.9% 2021 -$10.55M +92.0% 2020 -$132.18M -303.9% 2019 -$32.73M -651.4% 2018 -$4.36M -675.3% … Read more
Quick Answer AMERICAN COASTAL INSURANCE Corp reported Shares Outstanding of 48.76 million shares for fiscal year 2025. AMERICAN COASTAL INSURANCE Corp Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 48.76M +1.2% 2024 48.20M +3.1% 2023 46.78M +8.1% 2022 43.28M -0.2% 2021 43.37M +0.7% 2020 43.08M +0.1% 2019 43.03M +0.1% 2018 42.98M … Read more